While cannabis and THC are controlled substances in Sweden, CBD, CBN and CBG are not, and oral solutions and solutions for inhalation containing CBD are considered medicinal products. This report provides a detailed overview of the current regulatory framework in place in Sweden for CBD, hemp and cannabis. In addition to information around extracts and finished products containing CBD, the country’s medical and recreational cannabis regimes are also discussed and a comprehensive list of relevant laws and bodies is included.
Lorenzo holds a masters degree in International Law from the University of Trento, Italy, where he specialised in aspects of European law. In 2017 he completed a six-month exchange programme with Erasmus+ in Tarragona, Spain. He has had work experience in the legal sector as an intern in a law firm and at the Court of Rovereto, Italy.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
"*" indicates required fields
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.